DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Sudeep Pharma Limited — Board Meeting Intimation

NSE 1 hr ago·25 Jul 2026, 7:26 am

Sudeep Pharma

Sudeep Pharma Limited has announced a board meeting scheduled for August 4, 2026. The primary agenda for this meeting is to review and approve the company's unaudited quarterly financial results for the period ending June 2026. Additionally, the board will consider other items of business.

This announcement is a routine corporate update that provides investors with a key timeline for receiving the company's performance data. Since the results are unaudited, they offer an initial glimpse into the company's operational health and financial trajectory for the quarter.

Investors should monitor the release of these results closely, as they will reflect the company's current market position and operational efficiency. This data will be crucial for assessing the stock's short-term performance and future direction.